D2G ONCOLOGY
D2G Oncology is a biotechnology company that specializes in relating drugs to genotypes to transform precision cancer therapeutics. The company was founded in 2018 and is headquartered in Mountain View, California.
D2G ONCOLOGY
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical Therapeutics
Founded:
2018-01-01
Address:
Mountain View, California, United States
Country:
United States
Website Url:
http://www.d2g-oncology.com
Total Employee:
11+
Status:
Active
Total Funding:
8.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Google
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Genomics
Genomics plc aiming to lead the genomic transformation of healthcare.
miRecule
MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics.
Prevtec microbia
Agri-food biotechnology company specialized in developing technologies and marketing
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.d2g-oncology.com Semrush global rank: 8.36 M Semrush visits lastest month: 319
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "D2G Oncology"
D2G Oncology - LinkedIn
D2G Oncology Biotechnology Research Mountain View, CA 682 followers Relating Drugs to Genotypes to Transform Precision Cancer TherapeuticsSee details»
D2G Oncology - PitchBook
D2G Oncology General Information Description. Developer of precision cancer therapeutics intended to transform the treatment of cancer. The company …See details»
D2G Oncology - The Org
D2G Oncology leverages quantitative and multiplexed functional cancer genomics to relate drugs to genotypes to transform precision cancer therapeutics. Industries. Biotechnology. …See details»
D2G ONCOLOGY, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for D2G ONCOLOGY, INC. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
D2G Oncology - Tech Stack, Apps, Patents & Trademarks
D2G Oncology is a biotechnology company that specializes in relating drugs to genotypes to transform precision cancer therapeutics. Search Crunchbase. Start Free Trial . Chrome …See details»
D2G Oncology - Crunchbase
D2G Oncology is a biotechnology company that specializes in relating drugs to genotypes to transform precision cancer therapeutics. Search Crunchbase. Start Free Trial . Chrome …See details»
D2G Oncology | Lightspeed | Venture Capital - lsvp.com
D2G Oncology leverages quantitative and multiplexed functional cancer genomics to relate drugs to genotypes to transform precision cancer therapeutics. Jonathan MacQuitty 7 Countries 1 Global CommunitySee details»
D2G Oncology - VentureRadar
Alterome Therapeutics USA Privately Held Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated …See details»
D2G Oncology's Leadership Team - Team members and org chart
About. The leadership team at D2G Oncology has a long history of experience in the field of oncology. The team has experience working at various companies in the industry, including …See details»
D2G Oncology - Products, Competitors, Financials, Employees ...
D2G Oncology was founded in 2018. Where is D2G Oncology's headquarters? D2G Oncology's headquarters is located at 297 N. Bernardo Avenue, Mountain View. What is D2G Oncology's …See details»
D2G Oncology - Craft
D2G Oncology has 5 employees at their 1 location. See insights on D2G Oncology including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
D2G Oncology - Funding, Financials, Valuation & Investors
D2G Oncology is a biotechnology company that specializes in relating drugs to genotypes to transform precision cancer therapeutics. Search Crunchbase. ... How much funding has this …See details»
Jonathan MacQuitty - Catalys Pacific
Prior to his current positions, Jonathan served as CEO of Forty Seven, an immuno-oncology company that completed a $113 million IPO in 2018, from its inception until 2017. From 1999 …See details»
D2G Oncology, Inc. | Institution outputs | Nature Index
May 1, 2023 D2G Oncology, Inc. Time frame: 1 May 2023 - 30 April 2024 View institution profile Region or country/territory Sector. Subject or journal group. Apply. Count: 1 Share: 0.56. …See details»
Oncogenic context shapes the fitness landscape of tumor …
Oct 12, 2023 D.A.P. and M.M.W. are co-founders, shareholders, members of the board of directors, and compensated scientific advisors of D2G Oncology. I.P.W., D.A.P., and M.M.W. …See details»
Relating Drugs to Genotypes to Transform Precision Cancer …
Sep 8, 2020 D2G Oncology, Inc. proposes to develop a novel preclinical experimental platform that will effectively relate cancer drugs to genotypes (?D2G?) to predict pharmacogenomic …See details»
D2G Oncology - Contacts, Employees, Board Members
Organization. D2G Oncology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... D2G Oncology has 2 current …See details»
Oncogenic context shapes the fitness landscape of tumor …
Oct 12, 2023 18 D2G Oncology, Mountain View, CA, USA. [email protected]. # Contributed equally. PMID: 37828026 PMCID: PMC10570323 DOI: 10.1038/s41467-023 …See details»
Combinatorial tumor suppressor inactivation efficiently initiates …
Oct 21, 2021 D.A.P. and M.M.W. are founders of, and hold equity in, D2G Oncology Inc. Lung cancer is the leading cause of cancer death worldwide, with lung adenocarcinoma being the …See details»